DNAnexus Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 150
Employees
  • Latest Deal Type
  • Series H
  • Latest Deal Amount
  • $100M
Latest Deal Amount
  • Investors
  • 21

DNAnexus General Information

Description

Developer of a biomedical informatics and data management platform designed to analyze DNA-sequencing data. The company's platform helps researchers across a spectrum of industries like biopharmaceutical, bio agricultural, sequencing services, clinical diagnostics, government and research consortia to accelerate their genomics programs globally, enabling commercial and academic medical researchers to visualize and analyze big data system for DNA from a single, unified system.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Discovery Tools (Healthcare)
Database Software
Primary Office
  • 1975 West El Camino Real
  • Suite 204
  • Mountain View, CA 94040
  • United States
+1 (650) 000-0000

DNAnexus Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DNAnexus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series H) 09-Jun-2020 $100M 00000 00000 Completed Generating Revenue
9. Later Stage VC (Series G) 06-Feb-2019 0000 00000 00000 Completed Generating Revenue
8. Later Stage VC (Series E) 02-Jan-2018 0000 00000 00000 Completed Generating Revenue
7. Debt - General 01-May-2017 0000 000.00 Completed Generating Revenue
6. Later Stage VC (Series D) 22-Apr-2015 0000 000.00 0000 Completed Generating Revenue
5. Later Stage VC 30-Jun-2014 000.00 Completed Generating Revenue
4. Debt - General 21-Mar-2014 000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 03-Jan-2014 0000 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 12-Oct-2011 $15.2M $16.7M 000.00 Completed Startup
1. Early Stage VC (Series A) 28-Jul-2009 $1.55M $1.55M 00.00 Completed Startup
To view DNAnexus’s complete valuation and funding history, request access »

DNAnexus Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series H 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series G 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series F-2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series F-1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series E 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 7,559,292 $0.001000 $0.16 $2.02 $2.02 1x $0.63 4.52%
Series A 1,347,823 $0.001000 $0.09 $1.15 $1.15 1x $0.47 0.62%
To view DNAnexus’s complete cap table history, request access »

DNAnexus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a biomedical informatics and data management platform designed to analyze DNA-sequencing data. The company'
Other Healthcare Technology Systems
Mountain View, CA
150 As of 2020
00000
0000 0000-00-00
00000000000 00000

00000 00

ng elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,
00000 0000000000 0000000000 0000000
London, United Kingdom
00.000
000000000000 00.000

000000

is aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
0000000000000
Palo Alto, CA
0 As of 0000
0000
0000000000 0 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DNAnexus Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eagle Genomics Venture Capital-Backed London, United Kingdom 00.000 000000000000 00.000
000000 Venture Capital-Backed Palo Alto, CA 0 0000 0000000000 0 0000
0000000 Formerly VC-backed Rijswijk, Netherlands 00 000.00 000000&0 000.00
00000000 Venture Capital-Backed New York, NY 00 000 0000000000 000
00 000000000 Venture Capital-Backed Zürich, Switzerland 00 000.00 00000000000 000.00
You’re viewing 5 of 33 competitors. Get the full list »

DNAnexus Executive Team (22)

Name Title Board Seat Contact Info
Richard Daly Chief Executive Officer & Board Member
Scott Gibson Chief Financial Officer
George Asimenos Ph.D Chief Technology Officer
Mark Swendsen Chief Revenue Officer
John Ellithorpe Ph.D Chief Product Officer & Executive Vice President
You’re viewing 5 of 22 executive team members. Get the full list »

DNAnexus Board Members (11)

Name Representing Role Since
Edward Hu Ph.D WuXi Healthcare Ventures Board Member 000 0000
Ge Li Ph.D WuXi Healthcare Ventures Board Member 000 0000
Geoffrey Duyk Ph.D TPG Biotech Board Member 000 0000
Hannes Smarason Genuity Science Board Member 000 0000
James Tananbaum MD Foresite Capital Management Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

DNAnexus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DNAnexus Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Northpond Ventures Venture Capital Minority 000 0000 000000 0
Perceptive Advisors Hedge Fund Minority 000 0000 000000 0
Regeneron Pharmaceuticals Corporation Minority 000 0000 000000 0
Innovatus Capital Partners Asset Manager Minority 000 0000 000000 0
TPG Growth PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »